Articles

Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials

Tchang BG, Knight MG, Adelborg K, et al.

First published: January 5, 2025  DOI: 10.1002/oby.24202